Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
Sales | 0 | 0 | 0 | 0 | 726 |
Gross Profit | N/A | N/A | N/A | N/A | 726 |
Operating Expenses | 3,014 | 3,367 | -909 | 1,885 | 2,834 |
Operating Income | -3,014 | -3,367 | -544 | -1,885 | -2,108 |
Interest Expense | 110 | 13 | 0 | 0 | 0 |
Other Income | 2 | 0 | -5 | 0 | 3 |
Pre-tax Income | -3,123 | -3,380 | -549 | -1,885 | -2,105 |
Net Income Continuous | -3,123 | -3,380 | -549 | -1,885 | -2,105 |
Net Income | $-3,123 | $-3,380 | $-549 | $-1,885 | $-2,105 |
EPS Basic Total Ops | -1.29 | -1.38 | 4.35 | -0.77 | -3.11 |
EPS Basic Continuous Ops | -1.29 | -1.38 | 4.35 | -0.77 | -3.11 |
EPS Diluted Total Ops | -1.29 | -1.38 | 4.35 | -0.77 | -3.11 |
EPS Diluted Continuous Ops | -1.29 | -1.38 | 4.35 | -0.77 | -3.11 |
EBITDA(a) | $-3,013 | $-3,366 | $910 | $-2,021 | $-2,042 |